TGF-β1与高血压及其靶器官关系的研究进展
Research Progress on the Relationship between TGF-β1 and Hypertension and Its Target Organs
DOI: 10.12677/acm.2025.1592544, PDF,   
作者: 杨桂平, 陈炳霖:右江民族医学院研究生学院,广西 百色;潘兴寿*:右江民族医学院附属医院心血管内科,广西 百色
关键词: 高血压TGF-β1靶器官损害Hypertension TGF-β1 Target Organ Damage
摘要: 高血压是全球范围内严重威胁人类健康的常见心血管疾病,其发病机制复杂多样。转化生长因子-β1 (TGF-β1)作为一种多功能细胞因子,近年来在高血压领域的研究中备受关注。本文对TGF-β1与高血压及其靶器官的关系进行综述,进一步阐述TGF-β1在高血压发生发展过程中对血管、心脏、肾脏等靶器官的作用机制。
Abstract: Hypertension is a common cardiovascular disease that seriously threatens human health worldwide, with complex and diverse pathogenesis. Transforming growth factor-β1 (TGF-β1), as a multifunctional cytokine, has attracted considerable attention in hypertension research in recent years. This article reviews the relationship between TGF-β1 and hypertension as well as its target organs, and further elaborates on the mechanism of action of TGF-β1 on target organs such as blood vessels, heart, and kidneys during the occurrence and development of hypertension.
文章引用:杨桂平, 陈炳霖, 潘兴寿. TGF-β1与高血压及其靶器官关系的研究进展[J]. 临床医学进展, 2025, 15(9): 692-698. https://doi.org/10.12677/acm.2025.1592544

参考文献

[1] Krzemień, S. and Knapczyk, P. (1960) Current Review on the Role of Transforming Growth Factor Beta (TGF-Beta) in Some Pathological Disorders. Wiadomości lekarskie, 58, Article 536.
[2] Kajdaniuk, D., Marek, B., Borgiel-Marek, H., et al. (2013) Transforming Growth Factor β1 (TGFβ1) in Physiology and Pathology. Endokrynologia Polska, 64, 384-396. [Google Scholar] [CrossRef] [PubMed]
[3] Gordon, K.J. and Blobe, G.C. (2008) Role of Transforming Growth Factor-β Superfamily Signaling Pathways in Human Disease. Biochimica et Biophysica ActaMolecular Basis of Disease, 1782, 197-228. [Google Scholar] [CrossRef] [PubMed]
[4] Wrana, J.L., Attisano, L., Cárcamo, J., Zentella, A., Doody, J., Laiho, M., et al. (1992) TGF-β Signals through a Heteromeric Protein Kinase Receptor Complex. Cell, 71, 1003-1014. [Google Scholar] [CrossRef] [PubMed]
[5] Akhurst, R.J. and Hata, A. (2012) Targeting the TGF-β Signalling Pathway in Disease. Nature Reviews Drug Discovery, 11, 790-811. [Google Scholar] [CrossRef] [PubMed]
[6] Kawabata, M. and Miyazono, K. (1999) Signal Transduction of the TGF-β Superfamily by Smad Proteins. Journal of Biochemistry, 125, 9-16. [Google Scholar] [CrossRef] [PubMed]
[7] Tzavlaki, K. and Moustakas, A. (2020) TGF-β Signaling. Biomolecules, 10, Article 487. [Google Scholar] [CrossRef] [PubMed]
[8] Heldin, C.H., Miyazono, K. and Ten Dijke, P. (1997) TGF-β Signalling from Cell Membrane to Nucleus through SMAD Proteins. Nature, 390, 465-471. [Google Scholar] [CrossRef] [PubMed]
[9] Gressner, A.M. (2002) Roles of TGF-β in Hepatic Fibrosis. Frontiers in Bioscience, 7, A812. [Google Scholar] [CrossRef] [PubMed]
[10] Liu, Y., Lin, Y., Huang, X., Li, Y., Liu, Y. and Shi, L. (2023) Association of Serum Transforming Growth Factor β1 with Left Ventricular Hypertrophy in Children with Primary Hypertension. European Journal of Pediatrics, 182, 5439-5446. [Google Scholar] [CrossRef] [PubMed]
[11] Laviades, C., Varo, N. and Díez, J. (2000) Transforming Growth Factor β in Hypertensives with Cardiorenal Damage. Hypertension, 36, 517-522. [Google Scholar] [CrossRef] [PubMed]
[12] Cambien, F., Ricard, S., Troesch, A., Mallet, C., Générénaz, L., Evans, A., et al. (1996) Polymorphisms of the Transforming Growth Factor-β1 Gene in Relation to Myocardial Infarction and Blood Pressure. Hypertension, 28, 881-887. [Google Scholar] [CrossRef] [PubMed]
[13] El-Gamel, A., Awad, M., Sim, E., Hasleton, P., Yonan, N., Egan, J., et al. (1998) Transforming Growth Factor-β1 and Lung Allograft Fibrosis. European Journal of Cardio-Thoracic Surgery, 13, 424-430. [Google Scholar] [CrossRef] [PubMed]
[14] Suthanthiran, M., Li, B., Song, J.O., et al. (2000) Transforming Growth Factor-β 1 Hyperexpression in African-American Hypertensives: A Novel Mediator of Hypertension and/or Target Organ Damage. Proceedings of the National Academy of Sciences, 97, 3479-3484. [Google Scholar] [CrossRef
[15] He, F., Zhao, D., Deng, F., Zhong, H., Shi, X., Yang, J., et al. (2010) Association of TGF-β1 Gene Polymorphisms in Exon1 and Blood Levels with Essential Hypertension. Blood Pressure, 19, 225-233. [Google Scholar] [CrossRef] [PubMed]
[16] Xi, B., Wang, Q. and Pan, H. (2012) Transforming Growth Factor-β1 Gene+869T/C, but Not+915G/C Polymorphism Is Associated with Essential Hypertension in a Chinese Patient Cohort. Molecular Biology Reports, 39, 6107-6112. [Google Scholar] [CrossRef] [PubMed]
[17] Khani, M., Amani, D., Taheripanah, R., Sanadgol, N., Feizollahzadeh, S. and Rahmani, Z. (2015) Transforming Growth Factor Beta-1 (TGF-β1) Gene Single Nucleotide Polymorphisms (SNPs) and Susceptibility to Pre-Eclampsia in Iranian Women: A Case-Control Study. Pregnancy Hypertension, 5, 267-272. [Google Scholar] [CrossRef] [PubMed]
[18] Zheng, N., Hu, X., Lin, L., Chen, L. and Guo, R. (2022) Association between Transforming Growth Factor-β 1 Polymorphisms and Risk of Pre-Eclampsia: A Meta-Analysis. The Journal of Maternal-Fetal & Neonatal Medicine, 35, 9470-9480. [Google Scholar] [CrossRef] [PubMed]
[19] 张燕, 卫玲, 刘媛媛, 等. 妊娠期高血压患者TGF-β1水平及其基因rs1800469 C/T位点多态性分析[J]. 中国优生与遗传杂志, 2020, 28(6): 679-681.
[20] Ohno, M., Cooke, J.P., Dzau, V.J. and Gibbons, G.H. (1995) Fluid Shear Stress Induces Endothelial Transforming Growth Factor β-1 Transcription and Production. Modulation by Potassium Channel Blockade. Journal of Clinical Investigation, 95, 1363-1369. [Google Scholar] [CrossRef] [PubMed]
[21] Ray, P.E., McCune, B.K., Gomez, R.A., Horikoshi, S., Kopp, J.B. and Klotman, P.E. (1993) Renal Vascular Induction of TGF-β2 and Renin by Potassium Depletion. Kidney International, 44, 1006-1013. [Google Scholar] [CrossRef] [PubMed]
[22] Verrecchia, F. and Mauviel, A. (2002) Transforming Growth Factor-β Signaling through the Smad Pathway: Role in Extracellular Matrix Gene Expression and Regulation. Journal of Investigative Dermatology, 118, 211-215. [Google Scholar] [CrossRef] [PubMed]
[23] Kim, H.S. and Kim, H.Y. (2022) Hypertensive Effects of Transforming Growth Factor-β1 in Vascular Smooth Muscles Cells from Spontaneously Hypertensive Rats Are Mediated by Sulfatase 2. Cytokine, 150, Article 155754. [Google Scholar] [CrossRef] [PubMed]
[24] Kurihara, H., Yoshizumi, M., Sugiyama, T., Takaku, F., Yanagisawa, M., Masaki, T., et al. (1989) Transforming Growth Factor-β Stimulates the Expression of Endothelin mRNA by Vascular Endothelial Cells. Biochemical and Biophysical Research Communications, 159, 1435-1440. [Google Scholar] [CrossRef] [PubMed]
[25] Zhang, Q., Liu, H. and Yang, J. (2019) Regulation of TGF‑β1 on PI3KC3 and Its Role in Hypertension‑Induced Vascular Injuries. Experimental and Therapeutic Medicine, 17, 1717-1727. [Google Scholar] [CrossRef] [PubMed]
[26] Kakoki, M., Pochynyuk, O.M., Hathaway, C.M., Tomita, H., Hagaman, J.R., Kim, H., et al. (2013) Primary Aldosteronism and Impaired Natriuresis in Mice Underexpressing TGF-β1. Proceedings of the National Academy of Sciences, 110, 5600-5605. [Google Scholar] [CrossRef] [PubMed]
[27] Tang, Y., Shen, L., Bao, J. and Xu, D. (2023) Deficiency of Tregs in Hypertension-Associated Left Ventricular Hypertrophy. The Journal of Clinical Hypertension, 25, 562-572. [Google Scholar] [CrossRef] [PubMed]
[28] Li, B., Khanna, A., Sharma, V., et al. (1999) TGF-β1 DNA Polymorphisms, Protein Levels, and Blood Pressure. Hypertension, 33, 271-275. [Google Scholar] [CrossRef] [PubMed]
[29] Kuwahara, F., Kai, H., Tokuda, K., Kai, M., Takeshita, A., Egashira, K., et al. (2002) Transforming Growth Factor-β Function Blocking Prevents Myocardial Fibrosis and Diastolic Dysfunction in Pressure-Overloaded Rats. Circulation, 106, 130-135. [Google Scholar] [CrossRef] [PubMed]
[30] Petrov, V.V., Fagard, R.H. and Lijnen, P.J. (2002) Stimulation of Collagen Production by Transforming Growth Factor-β 1 during Differentiation of Cardiac Fibroblasts to Myofibroblasts. Hypertension, 39, 258-263. [Google Scholar] [CrossRef] [PubMed]
[31] Sappino, A.P., Schürch, W. and Gabbiani, G. (1990) Differentiation Repertoire of Fibroblastic Cells: Expression of Cytoskeletal Proteins as Marker of Phenotypic Modulations. Laboratory Investigation, 63, 144-161.
[32] Zhang, Y., Wang, Y., Liu, Y., Wang, N., Qi, Y. and Du, J. (2013) Krüppel-Like Factor 4 Transcriptionally Regulates TGF-β1 and Contributes to Cardiac Myofibroblast Differentiation. PLOS ONE, 8, e63424. [Google Scholar] [CrossRef] [PubMed]
[33] Kapoun, A.M., Liang, F., O’Young, G., Damm, D.L., Quon, D., White, R.T., et al. (2004) B-Type Natriuretic Peptide Exerts Broad Functional Opposition to Transforming Growth Factor-β in Primary Human Cardiac Fibroblasts. Circulation Research, 94, 453-461. [Google Scholar] [CrossRef] [PubMed]
[34] Watson, C.J., Phelan, D., Xu, M., Collier, P., Neary, R., Smolenski, A., et al. (2012) Mechanical Stretch Up-Regulates the B-Type Natriuretic Peptide System in Human Cardiac Fibroblasts: A Possible Defense against Transforming Growth Factor-β Mediated Fibrosis. Fibrogenesis & Tissue Repair, 5, Article No. 9. [Google Scholar] [CrossRef] [PubMed]
[35] Liu, Y., Lv, H., Tan, R., et al. (2020) Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting with Fibroblasts. Hypertension, 76, 1856-1867. [Google Scholar] [CrossRef] [PubMed]
[36] Tian, J., Li, W., Zeng, L., et al. (2024) HBI-8000 Improves Heart Failure with Preserved Ejection Fraction via the TGF-β1/MAPK Signalling Pathway. Journal of Cellular and Molecular Medicine, 28, e18238. [Google Scholar] [CrossRef] [PubMed]
[37] Susic, D., Frohlich, E.D., Kobori, H., Shao, W., Seth, D. and Navar, L.G. (2011) Salt-Induced Renal Injury in SHRs Is Mediated by AT1 Receptor Activation. Journal of Hypertension, 29, 716-723. [Google Scholar] [CrossRef] [PubMed]
[38] Frangogiannis, N.G. (2020) Transforming Growth Factor-β in Tissue Fibrosis. Journal of Experimental Medicine, 217, e20190103. [Google Scholar] [CrossRef] [PubMed]
[39] Tomasek, J.J., Gabbiani, G., Hinz, B., Chaponnier, C. and Brown, R.A. (2002) Myofibroblasts and Mechano-Regulation of Connective Tissue Remodelling. Nature Reviews Molecular Cell Biology, 3, 349-363. [Google Scholar] [CrossRef] [PubMed]
[40] Li, L., Xia, G., Lei, L., et al. (2025) Role of TGF-β1/Smad3 Signalling Pathway in Renal Tubulointerstitial Fibrosis and Renal Damage in Elderly Rats with Isolated Systolic Hypertension Induced by Increased Pulse Pressure. Acta Cardiologica, 80, 135-147. [Google Scholar] [CrossRef] [PubMed]
[41] 李璐, 陈春艳, 杨冬花, 等. 脉压增大对老年单纯收缩期高血压大鼠肾脏纤维化的影响及其机制[J]. 中国老年学杂志, 2024, 44(17): 4301-4305.
[42] Hu, H., Chen, D., Wang, Y., Feng, Y., Cao, G., Vaziri, N.D., et al. (2018) New Insights into TGF-β/Smad Signaling in Tissue Fibrosis. Chemico-Biological Interactions, 292, 76-83. [Google Scholar] [CrossRef] [PubMed]
[43] Panizo, S., Martínez-Arias, L., Alonso-Montes, C., Cannata, P., Martín-Carro, B., Fernández-Martín, J.L., et al. (2021) Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences. International Journal of Molecular Sciences, 22, Article 408. [Google Scholar] [CrossRef] [PubMed]
[44] Huo, J., Jiao, L., An, Q., Chen, X., Qi, Y., Wei, B., et al. (2021) Myofibroblast Deficiency of LSD1 Alleviates TAC-Induced Heart Failure. Circulation Research, 129, 400-413. [Google Scholar] [CrossRef] [PubMed]
[45] Ye, S., Huang, H., Xiao, Y., Han, X., Shi, F., Luo, W., et al. (2023) Macrophage Dectin-1 Mediates Ang II Renal Injury through Neutrophil Migration and TGF-β1 Secretion. Cellular and Molecular Life Sciences, 80, Article No. 184. [Google Scholar] [CrossRef] [PubMed]